Why Science? | Institute of Molecular and Cell Biology

A*STAR describes IMCB as a biomedical research institute harnessing biology for biotherapeutics and diagnostics. Its strategic divisions connect fundamental questions with technology platforms and clinical collaborators. The institute’s scope is broad, so each claim should name the actual division, model and released study involved.

Cell and molecular biology connects invisible mechanisms to measurable changes in cells, tissues and organisms; each scale needs a suitable model and control. The chapter develops institutional literacy. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Draw the three official research divisions and a question each is equipped to ask. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: An institute mission is not evidence that a particular therapy works.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Next chapter

A cell maintains boundaries, energy, information flow and repair while responding to its surroundings. Molecular and cell biology asks how DNA, RNA, proteins, lipids and metabolites cooperate in these functions. Measurements at one layer become more useful when linked to a defined cellular behaviour.

A promising target or molecule begins a translation pathway rather than ending one: reproducibility, safety, dose, delivery and clinical evidence still have to be earned. The chapter develops cell-systems reasoning. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Choose one cell process and map molecule, organelle and observable outcome. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A molecular change may be a consequence rather than a cause.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Receptors and intracellular pathways transmit information that can alter growth, movement, metabolism or death. Signals branch and cross-talk, so blocking one component may have different effects across cell types. Mechanistic experiments need perturbations, controls, time courses and alternative explanations.

Cross-disciplinary biomedical teams combine basic scientists, engineers, clinicians and platform specialists, so roles and evidence ownership should be stated rather than assumed. The chapter develops mechanistic experiment design. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Design a signalling experiment with a perturbation and rescue control. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Pathway diagrams simplify dynamic, context-dependent interactions.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

IMCB’s cancer division examines signalling, stem-cell relationships, epigenetics, structure and preclinical or clinical models. Tumours evolve diverse cell populations under environmental and treatment pressures. One sample or marker rarely captures that diversity, making longitudinal and spatial evidence valuable.

Models such as organoids, zebrafish or mice answer bounded questions and can inform human biology without becoming miniature substitutes for people. The chapter develops cancer-systems literacy. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a tumour-evidence map across cells, space, time and treatment. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A laboratory cancer marker is not automatically prognostic or druggable.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Chemical marks and chromatin organisation influence which genes are accessible without changing the DNA letters. Epigenetic patterns can respond to development, ageing, environment and disease. Experiments must distinguish correlation from a causal regulatory role and account for mixed cell populations.

Cell and molecular biology connects invisible mechanisms to measurable changes in cells, tissues and organisms; each scale needs a suitable model and control. The chapter develops epigenetic reasoning. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Compare an observational epigenetic study with a perturbation study. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: An epigenetic association does not prove inheritance or personal fate.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Proteins and complexes act through three-dimensional structures that change with partners and conditions. Structural methods and computation provide complementary views, each with resolution and preparation limits. A structure can suggest a binding site while biochemical and cellular tests examine whether it matters.

A promising target or molecule begins a translation pathway rather than ending one: reproducibility, safety, dose, delivery and clinical evidence still have to be earned. The chapter develops structure-function analysis. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Trace a candidate binding site from structure to functional assay. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A visually convincing docking pose is not binding or therapeutic evidence.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Stem cells can self-renew and differentiate into specialised cell types under suitable signals. Research measures identity, stability, function and unwanted states across passages. Regenerative promise depends on controlled production and safety, not on the word “stem” alone.

Cross-disciplinary biomedical teams combine basic scientists, engineers, clinicians and platform specialists, so roles and evidence ownership should be stated rather than assumed. The chapter develops stem-cell evidence. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a stem-cell quality card with identity, purity and functional measures. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Differentiation in culture is not proof of safe tissue regeneration in people.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Three-dimensional organoids can reproduce aspects of tissue architecture and cell interaction. They support disease modelling and candidate testing, while lacking many vascular, immune, mechanical and whole-body features. Researchers should state which feature the organoid represents and validate key findings elsewhere.

Models such as organoids, zebrafish or mice answer bounded questions and can inform human biology without becoming miniature substitutes for people. The chapter develops model validity. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Write an organoid model claim with represented and missing features. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: An organoid is not a complete miniature organ or patient.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Generating a cell type is only an early step. Therapeutic research asks whether cells survive, integrate, perform the intended function and avoid abnormal growth or immune harm. Delivery, dose and manufacturing consistency become part of the biological evidence.

Cell and molecular biology connects invisible mechanisms to measurable changes in cells, tissues and organisms; each scale needs a suitable model and control. The chapter develops regenerative translation. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Map identity, delivery, integration, function and safety as separate gates. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Cell survival alone does not establish regeneration or patient benefit.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Immune cells and engineered molecules may recognise or alter cancer cells, but tumours can suppress immunity and healthy tissues can share targets. Researchers examine specificity, potency, persistence and toxicity with suitable models. A strong response in vitro does not settle dosing or safety.

A promising target or molecule begins a translation pathway rather than ending one: reproducibility, safety, dose, delivery and clinical evidence still have to be earned. The chapter develops immunotherapy evaluation. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a target-benefit-off-target evidence triangle. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Preclinical immune activity is not an approved cancer treatment.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Proteins, nucleic acids and other biomolecules can be engineered for binding, stability, delivery or controlled activity. Each design change may introduce a trade-off in function, manufacturability or immune response. Versioned sequence, formulation and assay records make those trade-offs inspectable.

Cross-disciplinary biomedical teams combine basic scientists, engineers, clinicians and platform specialists, so roles and evidence ownership should be stated rather than assumed. The chapter develops biomolecular design. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Build a design-change table with benefit, new risk and confirming assay. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Optimised molecular properties do not establish clinical efficacy.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

IMCB’s neurometabolism division studies how metabolic state affects brain function and how the brain regulates feeding and organs. The work spans behaviour, circuits, cells, organelles, microbiomes and human data. Cross-scale claims need evidence that bridges these levels rather than assuming one explains all.

Models such as organoids, zebrafish or mice answer bounded questions and can inform human biology without becoming miniature substitutes for people. The chapter develops cross-scale physiology. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Map one brain-body question across organism, tissue, cell and molecule. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A finding in one scale or model may not transfer directly to human health.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Nutrients, microbial communities and metabolites may interact with brain and peripheral function. Diet, medication, geography and sampling can confound associations. Controlled experiments and longitudinal evidence help distinguish plausible mechanisms from a microbiome signature that merely travels with disease.

Cell and molecular biology connects invisible mechanisms to measurable changes in cells, tissues and organisms; each scale needs a suitable model and control. The chapter develops microbiome study design. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Write a microbiome claim with confounders and a follow-up experiment. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A microbiome association does not justify a supplement or treatment recommendation.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

IMCB describes zebrafish and mouse models alongside human-derived cells and organoids. Models allow controlled perturbation of mechanisms that cannot be tested directly in people, yet species and model construction affect transfer. Ethical review and the principles of replacement, reduction and refinement govern use.

A promising target or molecule begins a translation pathway rather than ending one: reproducibility, safety, dose, delivery and clinical evidence still have to be earned. The chapter develops preclinical model literacy. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: State why a model is needed and which human evidence will test transfer. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: Animal-model success does not guarantee human safety or efficacy.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Shared platforms can provide specialised imaging, proteomics, screening or model-development capability with standard procedures and expert staff. Platform output still needs project-specific controls, calibration and interpretation. Service quality and scientific meaning are related but distinct responsibilities.

Cross-disciplinary biomedical teams combine basic scientists, engineers, clinicians and platform specialists, so roles and evidence ownership should be stated rather than assumed. The chapter develops research-platform literacy. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a handoff record from research question to platform output and interpretation. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: An advanced instrument does not compensate for a weak biological question.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

IMCB-style research draws on biology, chemistry, medicine, engineering, microscopy, computation, statistics and ethics. Students can practise with safe model systems, public data and reproducible notebooks. Current education providers and institutions control course entry, laboratory access and professional qualifications.

Models such as organoids, zebrafish or mice answer bounded questions and can inform human biology without becoming miniature substitutes for people. The chapter develops biomedical career preparation. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Plan a small study pairing one biological question with one measurement and one baseline. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: A school investigation does not qualify someone to make treatment claims.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter · Next chapter

Archive the biological question, construct or sample, model, protocol, controls, raw measurements, analysis version, replication, mechanism claim, candidate identity, safety evidence, intended use and review status. This record separates discovery, preclinical promise and authorised clinical evidence.

Cell and molecular biology connects invisible mechanisms to measurable changes in cells, tissues and organisms; each scale needs a suitable model and control. The chapter develops evidence governance. Keep the question, input provenance, method version, control or baseline, uncertainty, review and next decision in one evidence receipt. That record shows what the research can support today and what still needs measurement, replication or governed approval. IMCB and its authorised partners control current projects, models and released results; ethics bodies, healthcare institutions and regulators control human research and clinical use.

Put this into practice by turning the idea into a small, reviewable action: Create a versioned mechanism-to-model-to-translation lineage. Then ask what the resulting note or artefact actually demonstrates. A useful record names context, source or instruction, action, observation, interpretation and uncertainty. It also preserves this limit: The latest authorised study, ethics decision and regulatory status control use.

An evidence check keeps confidence proportional to what the work can show. Separate the original observation or official statement from the learner’s explanation. Record feedback and any revision. If information is missing, write “not shown” or “not yet known” rather than guessing. That honest gap can become the next question.

Contents · Previous chapter